Waters (NYSE:WAT) Price Target Raised to $410.00

Waters (NYSE:WAT) had its price target increased by equities research analysts at TD Cowen from $363.00 to $410.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage currently has a “hold” rating on the medical instruments supplier’s stock. TD Cowen’s price objective would suggest a potential upside of 6.76% from the stock’s current price.

Several other equities research analysts have also weighed in on the stock. Sanford C. Bernstein upped their target price on shares of Waters from $345.00 to $360.00 and gave the stock a “market perform” rating in a report on Monday. Leerink Partners upgraded shares of Waters from a “market perform” rating to an “outperform” rating and upped their price target for the stock from $325.00 to $375.00 in a research report on Thursday, August 1st. Stifel Nicolaus upped their target price on shares of Waters from $332.00 to $360.00 and gave the company a “hold” rating in a research report on Monday. Wells Fargo & Company increased their price target on shares of Waters from $380.00 to $415.00 and gave the company an “overweight” rating in a research report on Monday. Finally, Leerink Partnrs upgraded shares of Waters from a “hold” rating to a “strong-buy” rating in a research report on Thursday, August 1st. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating, three have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $364.69.

Waters Stock Down 0.8 %

NYSE WAT traded down $3.17 during trading on Monday, reaching $384.04. The company’s stock had a trading volume of 384,099 shares, compared to its average volume of 429,061. The company has a current ratio of 2.10, a quick ratio of 1.42 and a debt-to-equity ratio of 1.42. The stock has a market capitalization of $22.80 billion, a PE ratio of 36.66, a PEG ratio of 6.35 and a beta of 0.97. The business has a 50-day moving average price of $342.04 and a 200-day moving average price of $325.28. Waters has a 1-year low of $241.95 and a 1-year high of $391.00.

Waters (NYSE:WAT) last released its earnings results on Friday, November 1st. The medical instruments supplier reported $2.93 EPS for the quarter, beating the consensus estimate of $2.68 by $0.25. The firm had revenue of $740.30 million during the quarter, compared to analysts’ expectations of $712.99 million. Waters had a net margin of 20.71% and a return on equity of 56.81%. The business’s quarterly revenue was up 4.0% compared to the same quarter last year. During the same period in the prior year, the company earned $2.84 EPS. On average, research analysts forecast that Waters will post 11.6 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of WAT. Mirae Asset Global Investments Co. Ltd. grew its holdings in shares of Waters by 12.4% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 22,134 shares of the medical instruments supplier’s stock worth $7,619,000 after purchasing an additional 2,448 shares during the last quarter. Tokio Marine Asset Management Co. Ltd. grew its holdings in shares of Waters by 25.4% during the first quarter. Tokio Marine Asset Management Co. Ltd. now owns 1,772 shares of the medical instruments supplier’s stock worth $610,000 after purchasing an additional 359 shares during the last quarter. Fidelis Capital Partners LLC bought a new stake in shares of Waters during the first quarter worth about $72,000. Daiwa Securities Group Inc. grew its holdings in shares of Waters by 9.9% during the first quarter. Daiwa Securities Group Inc. now owns 9,387 shares of the medical instruments supplier’s stock worth $3,231,000 after purchasing an additional 842 shares during the last quarter. Finally, BI Asset Management Fondsmaeglerselskab A S grew its holdings in shares of Waters by 71.8% during the first quarter. BI Asset Management Fondsmaeglerselskab A S now owns 2,601 shares of the medical instruments supplier’s stock worth $895,000 after purchasing an additional 1,087 shares during the last quarter. Institutional investors own 94.01% of the company’s stock.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.